. The current DSM5 lists 23 symptoms that need to be present in a variety of combinations to qualify someone as suffering from PTSD, contributing to a heterogeneity of the disorder. . New questions emerge about the complexity of the disorder, for example, the dissociative element, and discussions of ''simple'' vs ''complex''. . The majority of people exposed to trauma will not be clinically affected. There are important notions about resilience, what drives resilience? . We revisit questions that drove the post war period of the First World War about stigma, moral weakness, or injury, and the discrimination of PTSD with ''visible'' disorders such as mild traumatic brain injury (mTBI). . The PTSD of today is a grimsy disorder, does not have a clear incubation time, and varies in its presentation in relation to the time of onset after exposure. . It is a disorder that for diagnosis is purely based on self-disclosure, self-observation. We seem to completely go beyond behavioral observations as important assessment elements, and do not use hetero-anamnestic information as a clinical or critical source of information. , allowing third parties to copy and redistribute the material in any medium or format, and to remix, transform, and build upon the material, for any purpose, even commercially, under the condition that appropriate credit is given, that a link to the license is provided, and that you indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. Perhaps most important of all, despite promising new findings, there is also still no ''biological qualifier,'' which serves to determine who is more or less likely to get it, if exposed. No ''mental Cooper test'' exists, that can help us to select who is susceptible to the disorder. We invest many resources since it is felt that this prediction will not only be possible but also desperately wanted. Militaries and other uniformed services are dying to know how to implement this in selection procedures (Yehuda et al., 2014) , saving young men and women from unnecessary suffering. How far are we from first implementation of biomarkers in selection procedures? Do we see breakthroughs emerging to support this? In our fourth decade of research since 1980 with rapid developments in (epi)genetics, optogenetics, and novel imaging methods, this may be not that far down the road (Vermetten, Baker, & Yehuda, 2015; Vermetten, Zohar, & Krugers, 2014) .
Psychological trauma has become an iconic element in our society. Starting little over 100 years ago, psychotraumology is like a fast moving train, with currently more than 2,500 scientific publications per year on the topic of PTSD. The field is presenting itself to a highly modernized world, where stakes are high and education of a discourse is highly needed, because trauma is not likely to disappear. The artificial dichotomy between vulnerability and resilience is challenged by increasing violence, natural, and manmade disasters, and by participation in small conflicts and big-scaled wars. Murray and Lopez predicted in the Lancet in 1997 that in 2020 war and violence would be ranked in the top 10 of ''disease burden'' (Murray & Lopez, 1997) . If they are right, this puts a burden on the society. Do we habituate? Or sensitize? Yet in some countries, academia is hesitant to embrace or acknowledge the impact for the small group that is suffering, or one is not thinking yet in terms of healing and supportive communities or societies. Maybe the most important lesson we learned over the last years is to acknowledge trauma, identify the ones affected in need, and prevent the ''engraving'' of the impact of the stress early. In order to do so, we must be able to identify the persons that are biologically vulnerable representing a vulnerable phenotype, in order to justify early treatment, or monitor the developmental course in the aftermath of trauma exposure recommendation and facilitate his or her empowerment.
